Meet
The Council Members

Ravi Tayi, MD, MPH

VP, Medical Affairs, Endo Pharmaceuticals 

Ravi has knowledge and expertise in all functions within Global Medical Affairs and Clinical Development. Expertise in drug, device and drug/device combinations with extensive experience in launching drugs and devices in multiple therapy areas.

Bill Strickland

Executive Director, Global Medical Resources AstraZeneca

Bill has extensive experience in Medical Affairs including both US and Global responsibilities. Bill’s areas of expertise include leadership of teams including cross functional and Global, IT platform development and implementation, MSL and MI capabilities, Innovation and Simplification.

Catrinel Galateanu, MD

VP, Head of Global Medical Affairs at UCB

Physician and senior pharmaceutical medicine leader passionate about delivering value for Patients and working for People. 

​

Thriving at the intersection of science, drug development and patient care. Humbled and excited by innovation in healthcare and pharmaceutical business & new opportunities to better serve the patients (precision medicine, digital, health ecosystem solutions).

David Tang, PharmD

Vice-President, Global Medical Affairs & Strategic Planning, Allergan

David leads the Global Medical Affairs and Chief Medical Office Strategic Planning organization comprised of the worldwide therapeutic area Medical Affairs, US MSL, post-approval trial management, publications and medical education teams.

Deb Long, MD

Sr. Vice President, Medical Affairs 
Vertex

Deborah held various leadership roles in medical affairs, including leading the US Medical Affairs COPD team at GSK, and the Americas Internal Medicine Medical Monitoring group at PRA. Deborah spent a decade practicing pulmonary and critical care medicine prior to joining the pharmaceutical industry.

Dominick Albano, PharmD, MBA

VP, Global Medical Information 
Pfizer

Dominick, one of the founding members of phactMI (Pharma Collaboration for Transparent Medical Information), has spent most of his industry career working in Medical Information and Medical Affairs. He developed the “Theory of MI Relativity”, which describes the importance of awareness, trust/quality, and access as critical factors in MI utility.

Isma Benattia, MD, MBA

Vice President Europe Medical Affairs, Amgen

Currently serves as the VP, Head of Medical Affairs Europe including the European headquarters and affiliate Medical Teams, across all therapeutic areas. Passionate about patient involvement in the Research & Development of innovative medicines, the life-cycle management of marketed products and is working extensively with various stakeholders to accelerate medication accesses

Jung Hyun Lee, PharmD

Sr. Director, Medical Information, AstraZeneca

Thoughtful, strategic and solutions-oriented leader committed to providing exceptional medical service.  Passionate about innovative and digital solutions that enable informed use of medicines for patient care. Specialties/Areas of interest: Team Leadership, Medical Affairs, Medical Information, Scientific Communications, Field Medical, Launch Excellence, Digital/Innovation

Jennifer Riggins

Global Medical Digital, Strategy and Capabilities, Eli Lilly and Past President, phactMI

Jennifer led the Lilly Medical Affairs digital transformation by creating the medical digital strategy, enabling delivery of an award-winning global web platform and customer experience, and establishing and implementing the medical affairs social media strategy.

Joanne Jani

Head Med Info & Communication, Novartis

As Head of PLS US Medical at Novartis, Joanne is responsible for leading a cross divisional department that supports all therapeutic areas of Novartis in the areas of Medical Information and Communication, Content Development and MSL Capability Training and Medical Compliance training.

Rafael Muniz, MD

VP, Global Medical Affairs, Mylan

A Pharmaceutical Executive with Extensive Experience in Clinical Development & Medical Affairs in the Pharmaceutical industry. Rafael is a highly motivated, bilingual, dedicated and experienced pharmaceutical industry global medical executive that delivers results with broad, cross-functional leadership. Currently heading a team of over 150 Medical Affairs professionals responsible for Medical Affairs activities across all geographies and several therapeutic areas.

Javier Coindreau

VP, Global Medical Affairs, Gilead Sciences

Global Medical Affairs and Clinical Research/Clinical Development with leadership experience and expertise across Therapeutic and development areas: 

• Inflammation (rheumatology, gastroenterology, pftalmology, and dermatology)

• Oncology/Hematology

• Rare Diseases

• Small molecules, Biotech and Biosimilars

Meg Heim, MBA

Vice President, Head of North America Diabetes and Cardiovascular Scientific Communications, 
Sanofi

Meg has reputation for successful partnerships with Corporate, Pharm and BioTech, Government, Advocacy and Academic groups to create consensus and build programs that create healthcare transformative change. She is a  strategic thinker who is adept at resolving complex issues. 

Michael Kavanaugh, BS, MBA

Executive Director, Clinical Development and Medical Affairs Effectiveness and Scientific Communications, Boehringer Ingelheim

Seasoned pharmaceutical executive with experience in Marketing, Sales Operations, Marketing Operations, Medical Affairs and Clinical Development. A change agent and leader with proven skills in agility and problem solving. In his current role Mike oversees the Publications, Medical Education, External Research, Medical Information, Medical/Customer Call Center as well as the Stakeholder Relations team.

Richard Swank, Ph.D

Executive Director and Head, US Medical Capabilities, Amgen

Richard heads US Medical Capabilities at Amgen encompassing medical liaisons across five therapeutic areas, the US Med Info Call Center, REMS, and US Medical Events. He has been at Amgen since 2003 and prior to that worked for Organon-Sanofi Synthelabo.

Robin Winter-Sperry, MD

Global Field Based Medical Excellence Head 
Sanofi Genzyme

Works transversely to contribute to internal working groups for process improvements, strategy and tactics. Leads Global FBM Strategy Development and Ensures clarity and harmonization of roles and responsibilities of the Field Based Medical (FBM)/MSL function across internal and external stakeholders worldwide.

Rick Harms, PharmD

Executive Director Medical Affairs, Merck

Former Intercontinental Regional Director & Head of Scientific Affairs at Amgen.

Sarah Guadagno

Vice President, Global Medical Communications, Alexion Pharmaceuticals

Medical Communications executive with extensive US and Global experience including strategic planning and building capabilities supporting Global Medical Affairs functions. Sarah has a successful track record of developing and leading high-performing Medical Communications teams in environments of rapid organizational growth